FRESTEDA – US Trademark 88188071 of Lundbeck LLC

Trademark image

FRESTEDA (U.S. Trademark Serial Number 88188071) is a United States trademark of Lundbeck LLC. The goods and services include: Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy and schizophrenia,; preparations, substances, reagents and agents for diagnostic and medical purposes . The correspondent is Alexander Reid of WHITE & CASE LLP.

This trademark was filed on November 09, 2018 as United States Trademark Application Serial Number 88188071. This trademark application is still pending and does not yet have a registration number.

Trademark PTO Status History

July 04, 2022 – ABANDONMENT – NO USE STATEMENT FILED

December 02, 2021 – NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

December 01, 2021 – SOU EXTENSION 5 GRANTED

November 23, 2021 – SOU EXTENSION 5 FILED

December 01, 2021 – CASE ASSIGNED TO INTENT TO USE PARALEGAL

November 23, 2021 – TEAS EXTENSION RECEIVED

November 16, 2021 – TEAS CHANGE OF CORRESPONDENCE RECEIVED

November 16, 2021 – TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

View full trademark status information at USPTO

Ownership History

Lundbeck LLC

Lundbeck LLC

View documents on file at USPTO

File a Trademark or Get Help With Trademark Law

Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.

Leave a Reply

Your email address will not be published. Required fields are marked *